Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (721-730 of 962) with videos related to

Pageof 97
Sort By:
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
Thrombosis and Haemostasis|June 24, 2020
Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding EventsHideyuki Kawashima, Chao Gao, Kuniaki Takahashi, et al.
Journal of the American College of Cardiology|September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHFAnkeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.
Journal of Clinical Lipidology|September 24, 2022
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromesPatrick M Moriarty, Philippe Gabriel Steg, Jennifer McGinniss, et al.
The American Journal of Medicine|March 17, 2022
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES TrialRenato D Lopes, Patrícia O Guimarães, Gregory G Schwartz, et al.
Stroke|June 7, 2017
Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.orgTakao Hoshino, Shinichiro Uchiyama, Lawrence K S Wong, et al.
European Heart Journal|October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn H Alexander, Renato D Lopes, Laine Thomas, et al.
Journal of the American College of Cardiology|September 9, 2017
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54Marc P Bonaca, Robert F Storey, Pierre Theroux, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 16, 2017
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking CountriesHalim Abboud, Leila Sissani, Julien Labreuche, et al.
Pageof 97

Showing results (721-730 of 962) with videos related to

Sort By:
Pageof 97
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
Thrombosis and Haemostasis|June 24, 2020
Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding EventsHideyuki Kawashima, Chao Gao, Kuniaki Takahashi, et al.
Journal of the American College of Cardiology|September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHFAnkeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.
Journal of Clinical Lipidology|September 24, 2022
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromesPatrick M Moriarty, Philippe Gabriel Steg, Jennifer McGinniss, et al.
The American Journal of Medicine|March 17, 2022
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES TrialRenato D Lopes, Patrícia O Guimarães, Gregory G Schwartz, et al.
Stroke|June 7, 2017
Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.orgTakao Hoshino, Shinichiro Uchiyama, Lawrence K S Wong, et al.
European Heart Journal|October 23, 2013
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn H Alexander, Renato D Lopes, Laine Thomas, et al.
Journal of the American College of Cardiology|September 9, 2017
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54Marc P Bonaca, Robert F Storey, Pierre Theroux, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 16, 2017
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking CountriesHalim Abboud, Leila Sissani, Julien Labreuche, et al.
Pageof 97